Sector Chart MannKind Corporation

Equities

MNKD

US56400P7069

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 21:00:00 06/02/2026 GMT			5-day change	1st Jan Change
5.780 ^USD	+4.90%		0.00%	+1.94%

01-26	Sector Update: Health Care Stocks Mixed Premarket Monday	MT
01-26	MannKind Corporation Announces FDA Approval of Updated Afrezza Label Providing Starting Dose Guidance When Switching from Multiple Daily Injections or Insulin Pump Mealtime Therapy	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Sector Bio Therapeutic Drugs

	Capi.	Finances	EV / Sales	P/E
MANNKIND CORPORATION	1.77B	-	-
ARGENX SE	50.29B
WUXI APPTEC CO., LTD.	42.11B
INSMED INCORPORATED	31.96B			-
BIONTECH SE	26.75B			-
WUXI BIOLOGICS (CAYMAN) INC.	19.95B